marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Sonoma Pharmaceuticals Financial Statements 2011-2024 | SNOA
Annual Financial Statements Sonoma Pharmaceuticals
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.64 M | 3.94 M | 3.08 K | 7.98 M | 7.5 M | 7.32 M | 17.2 M | 29 M | 16.3 M | 7.44 M | 20.6 M | 26.2 M | 28.2 M | 51.2 M |
Shares |
9.09 M | 3.39 M | 2.65 K | 2 M | 1.48 M | 924 K | 503 K | 474 K | 365 K | 215 K | 153 K | 111 K | 86.9 K | 83.7 K |
Historical Prices |
0.18 | 1.16 | 1.16 | 4.56 | 7.26 | 4.36 | 6.39 | 49 | 45.4 | 51.8 | 64.3 | 157 | 192 | 331 |
Net Income |
-4.84 M | -5.15 M | -5.09 M | -3.95 M | -2.95 M | -11.8 M | -14.3 M | 9.27 M | -10.2 M | -8.2 M | 3.74 M | -5.43 M | -7.33 M | -7.95 M |
Revenue |
12.7 M | 13.3 M | 12.6 M | 18.6 M | 18.9 M | 19 M | 16.7 M | 12.8 M | 15.1 M | 13.9 M | 13.7 M | 15.5 M | 12.7 M | 9.75 M |
Cost of Revenue |
7.99 M | 8.8 M | 8.64 M | 12.1 M | 9.81 M | 10.1 M | 9.35 M | 7.16 M | 6.72 M | 6.57 M | 5.27 M | 4.71 M | 4.03 M | 3.61 M |
Gross Profit |
4.74 M | 4.48 M | 3.99 M | 6.56 M | 8.33 M | 8.88 M | 7.31 M | 5.67 M | 7.21 M | 7.29 M | 8.4 M | 10.7 M | 8.71 M | 6.14 M |
Operating Income |
-4.7 M | -4.57 M | -5.89 M | -3.45 M | -7.39 M | -11.3 M | -14.2 M | -13 M | -14.7 M | -6.66 M | -6.05 M | -3.37 M | -6.47 M | -7.5 M |
Interest Expense |
- | - | -10 K | 12 K | 16 K | 33 K | 40 K | 3 K | 3 K | 3 K | 1.06 M | 1.11 M | 931 K | 406 K |
EBITDA |
-4.52 M | -4.44 M | -5.7 M | -3.22 M | -6.36 M | -10.8 M | -13.7 M | -12.7 M | -9.91 M | -6.41 M | -5.77 M | -3.11 M | -6.14 M | -7.11 M |
Operating Expenses |
9.45 M | 9.05 M | 9.88 M | 10 M | 15 M | 20.1 M | 21.5 M | 18.6 M | 17.4 M | 13.9 M | 14.4 M | 14.1 M | 15.2 M | 13.6 M |
General and Administrative Expenses |
7.58 M | 8.84 M | 9.76 M | 9.45 M | 13.7 M | 18.6 M | 19.9 M | 17.1 M | 15.6 M | 12.4 M | 11.6 M | 11.9 M | 13.2 M | 11.6 M |
All numbers in USD currency
Quarterly Income Statement Sonoma Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
1.03 M | 17 M | 780 K | 10.9 M | 258 K | 4.94 M | 4.93 M | 3.11 M | 3.1 K | 3.1 K | 3.1 M | 3.08 K | 2.51 K | 2.22 K | 2.09 M | 2.05 K | 2.01 M | 2.01 M | 1.84 M | 1.5 M | 1.32 M | 1.32 M | 1.32 M | 971 K | 8.74 M | 693 K | 686 K | 4.39 M | 4.31 M | 4.29 M | 4.29 M | 4.22 M | 4.21 M | 4.2 M | 4.2 M | 3.29 M | 3.2 M | 3.14 M | 15 M | 8.6 M | 8.49 M | 8.42 M | 8.16 M | 6.81 K | 6.69 K | 6.62 K | 6.58 M | 5.13 M | 4.77 M | 4.59 K | 4.14 M | 27 M | 26.9 K | 26.8 K | 26.6 M |
Net Income |
-610 K | -1.14 M | - | -866 K | -1.48 M | -1.42 M | - | -1.94 M | -1.02 M | -887 K | - | -944 K | -2.14 M | -1.1 M | -1.1 M | -650 K | -650 K | 120 K | 240 K | -1.08 M | -1.08 M | -1.2 M | 715 K | -2.3 M | -2.3 M | -2.82 M | - | -3.19 M | -2.87 M | -3.51 M | - | 16.2 M | 11.7 M | -4.52 M | - | -3.15 M | -7.25 M | -4.1 M | - | -5.91 M | -6.7 M | -788 K | - | -611 K | -3.72 M | -3.11 M | - | -1.91 M | -2.99 M | -1.07 M | - | -2.55 M | -5.56 M | -3.01 M | - |
Revenue |
3.58 M | 3.39 M | - | 3.14 M | 2.73 M | 3.43 M | - | 2.94 M | 3.33 M | 3.98 M | - | 2.9 M | 10.3 M | 7.43 M | - | 4.94 M | 4.94 M | 5.77 M | 5.77 M | 4.68 M | 14.4 M | 9.68 M | - | 5.28 M | 5.28 M | 4.94 M | - | 4.84 M | 4.32 M | 3.84 M | - | 3.36 M | 8.8 M | 5.44 M | - | 2.48 M | 6.79 M | 7.73 M | - | 3.22 M | 9.87 M | 6.66 M | - | 3.29 M | 10.8 M | 7.46 M | - | 3.54 M | 12.1 M | 8.58 M | - | 2.79 M | 3.66 M | 2.94 M | - |
Cost of Revenue |
2.22 M | 2.08 M | - | 1.68 M | 1.74 M | 2.22 M | - | 2.11 M | 1.8 M | 2.34 M | - | 1.7 M | 6.43 M | 4.73 M | - | 2.94 M | 2.94 M | 3.27 M | 3.51 M | 2.39 M | 2.52 M | 2.67 M | 2.34 M | 2.43 M | 2.43 M | 2.51 M | - | 2.48 M | 2.48 M | 2.07 M | - | 1.66 M | 5.08 M | 3.42 M | - | 2.03 M | 5.12 M | 3.77 M | - | 1.56 M | 4.58 M | 3.02 M | - | 1.18 M | 3.74 M | 2.56 M | - | 1.07 M | 3.56 M | 32 K | - | 938 K | 2.81 M | 20 K | - |
Gross Profit |
1.36 M | 1.31 M | - | 1.46 M | 990 K | 1.2 M | - | 831 K | 1.54 M | 1.65 M | - | 1.2 M | 3.9 M | 2.69 M | - | 2 M | 2 M | 2.5 M | 2.26 M | 2 M | 2.16 M | 2.29 M | 2.37 M | 2.85 M | 2.85 M | 2.43 M | - | 2.37 M | 1.85 M | 1.76 M | - | 1.71 M | 3.72 M | 2.02 M | - | 455 K | 1.68 M | 3.96 M | - | 1.66 M | 5.29 M | 3.64 M | - | 2.11 M | 7.01 M | 4.9 M | - | 2.47 M | 8.56 M | 6.08 M | - | 1.85 M | 6.58 M | 4.73 M | - |
Operating Income |
-850 K | -1.17 M | - | -844 K | -1.21 M | -1.24 M | - | -1.83 M | -731 K | -855 K | - | -958 K | -2.83 M | -1.87 M | - | -138 K | -138 K | 169 K | -665 K | -1.11 M | -982 K | -1.2 M | -1.73 M | -2.35 M | -2.35 M | -2.65 M | - | -3.2 M | -2.86 M | -3.38 M | - | -3.56 M | -10.1 M | -6.5 M | - | -4.19 M | -11.1 M | -4.17 M | - | -1.95 M | -5.01 M | -3.06 M | - | -1.55 M | -3.94 M | -2.4 M | - | -680 K | -1.99 M | -1.31 M | - | -2.35 M | -5 M | -2.65 M | - |
Interest Expense |
- | - | - | - | - | - | - | 1 K | 4 K | 3 K | - | 3 K | -1 K | -5 K | - | 5 K | 12 K | 6 K | 2 K | 1 K | 1 K | 2 K | 10 K | 7 K | 7 K | 7 K | - | 11 K | 10 K | 10 K | - | - | 2 K | 2 K | - | - | 1 K | 1 K | - | - | 4 K | 4 K | - | 618 K | 1.06 M | 438 K | - | 275 K | 843 K | 568 K | - | 260 K | 652 K | 392 K | - |
EBITDA |
- | -1.13 M | - | - | - | -1.2 M | - | -1.83 M | -640 K | -824 K | - | -958 K | -2.69 M | -1.77 M | - | -138 K | 49 K | 276 K | -612 K | -1.11 M | -770 K | -1.06 M | -1.65 M | -2.35 M | -2 M | -2.41 M | - | -3.2 M | -2.86 M | -3.27 M | - | -3.56 M | -9.88 M | -6.38 M | - | -4.19 M | -10.9 M | -4.05 M | - | -1.95 M | -4.82 M | -2.96 M | - | -1.55 M | -3.73 M | -2.26 M | - | -680 K | -1.8 M | -1.18 M | - | -2.35 M | -4.76 M | -2.48 M | - |
Operating Expenses |
2.21 M | 2.48 M | - | 2.3 M | 2.2 M | 2.44 M | - | 2.66 M | 2.27 M | 2.5 M | - | 2.16 M | 6.72 M | 4.56 M | - | 2.13 M | 2.13 M | 2.33 M | 2.92 M | 3.11 M | 3.14 M | 3.5 M | 4.1 M | 5.2 M | 5.2 M | 5.08 M | - | 5.57 M | 4.7 M | 5.14 M | - | 5.27 M | 13.8 M | 8.51 M | - | 4.64 M | 12.8 M | 8.13 M | - | 3.6 M | 10.3 M | 6.7 M | - | 3.66 M | 11 M | 7.3 M | - | 3.15 M | 10.5 M | 7.4 M | - | 4.21 M | 11.6 M | 7.38 M | - |
General and Administrative Expenses |
1.7 M | 2.01 M | - | 1.7 M | 1.66 M | 2.12 M | - | 2.66 M | 2.07 M | 2.3 M | - | 2.14 M | 6.6 M | 4.47 M | - | 2.1 M | 2.1 M | 2.42 M | 2.44 M | 2.86 M | 2.89 M | 3.23 M | 3.76 M | 4.75 M | 4.75 M | 4.69 M | - | 5.22 M | 4.34 M | 4.76 M | - | 4.78 M | 12.6 M | 7.77 M | - | 4.16 M | 11.4 M | 7.25 M | - | 3.24 M | 9.14 M | 5.9 M | - | 2.88 M | 8.79 M | 5.91 M | - | 2.64 M | 8.99 M | 6.35 M | - | 3.7 M | 10.1 M | 6.38 M | - |
All numbers in USD currency